2.37
1.66%
-0.04
Handel nachbörslich:
2.40
0.03
+1.27%
Finanzdaten der Editas Medicine Inc-Aktie (EDIT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
98.11%
1.135
|
60.05 | 5.336 | 2.887 | 9.851 |
Operating Expenses
|
18.91%
68.13
|
84.01 | 55.50 | 46.98 | 60.81 |
Benefits Costs and Expenses |
-
|
- | - | - | 58.89 |
Costs And Expenses |
18.91%
68.13
|
84.01 | 55.50 | 46.98 | 58.89 |
Operating Income/Loss |
179.57%
-66.99
|
-23.96 | -50.16 | -44.09 | -50.96 |
Nonoperating Income/Loss |
0.92%
5.041
|
5.088 | 5.144 | 3.804 | 1.925 |
Income/Loss From Continuing Operations Before Tax |
98.11%
1.135
|
60.05 | 5.336 | -40.29 | -49.04 |
Income/Loss From Continuing Operations After Tax |
228.23%
-61.95
|
-18.87 | -45.02 | -40.29 | -49.04 |
Net Income/Loss
|
228.23%
-61.95
|
-18.87 | -45.02 | -40.29 | -49.04 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,132%
81.94
|
1.936 | 81.65 | 71.38 | 68.92 |
Diluted Average Shares |
4,132%
81.94
|
1.936 | 81.65 | 71.38 | 68.92 |
Basic Earnings Per Share |
261.90%
-0.76
|
-0.21 | -0.55 | -0.56 | -0.71 |
Diluted Earnings Per Share |
261.90%
-0.76
|
-0.21 | -0.55 | -0.56 | -0.71 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):